Publications by authors named "Anneline Cremer"

Claim this Profile
R
Real-world validation of a prognostic clinical index to predict steroid response in acute severe colitis: a single tertiary centre retrospective study.
Vincent Bouillon, Christophe De Terwangne, Claire Liefferinckx, Charlotte Minsart, Leila Amininejad, Anneline Cremer

Gut· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class.
Tommaso Innocenti, Jurij Hanžel, Marie Truyens, Milan Lukaš, Hannah Gordon, Anneline Cremer

J Crohns Colitis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ustekinumab in Ulcerative Colitis: A Real-Life Effectiveness Study Across Multiple Belgian Centers (SULTAN).
Tom Holvoet, Marie Truyens, Catherine Reenaers, Filip Baert, Stijn Vanden Branden, Anneline Cremer

J Clin Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study.
Maria Cristina Conti Bellocchi, Martina Cattani Mottes, Andreas Blesl, Anneline Cremer, Stefano Festa

Medicina (Kaunas)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in fatigue in patients with ulcerative colitis or Crohn's disease initiating biologic therapy.
Edouard Louis, Peter Bossuyt, Arnaud Colard, Antoine Nakad, Didier Baert, Anneline Cremer

Dig Liver Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A transcriptomic score to classify the inflammation-dysplasia-cancer sequence lesions in inflammatory bowel disease.
Anneline Cremer, Nicolas Rosewick, Maxfield Kelsey, Eric Trépo, Frédérick Libert

J Crohns Colitis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
Dahham Alsoud, João Sabino, Denis Franchimont, Anneline Cremer, Julie Busschaert

Inflamm Bowel Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Biological Therapies and Small Molecules in Ulcerative Proctitis: A Belgian Multicenter Cohort Study.
Pauline Lemmens, Edouard Louis, Wouter Van Moerkercke, Lieven Pouillon, Michael Somers, Anneline Cremer

Clin Gastroenterol Hepatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case series.
Hussein Mahajna, Bram Verstockt, Daniel Bergemalm, Fabiana Castiglione, Fransisco Rodríguez-Moranta, Anneline Cremer

J Crohns Colitis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive models assessing the response to ustekinumab highlight the value of therapeutic drug monitoring in Crohn's disease.
Claire Liefferinckx, Antoine Hubert, Debby Thomas, Jérémie Bottieau, Charlotte Minsart, Anneline Cremer

Dig Liver Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial.
Marie Truyens, Triana Lobatón, Marc Ferrante, Peter Bossuyt, Séverine Vermeire, Anneline Cremer

Gastroenterology· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study.
Laurent Goessens, Jean-Frédéric Colombel, An Outtier, Marc Ferrante, Joao Sabino, Anneline Cremer

United European Gastroenterol J· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Third-Class Biologic Treatment in Crohn's Disease: A Multi-Center Retrospective Cohort Study.
Ahmad Albshesh, Joshua Taylor, Edoardo V Savarino, Marie Truyens, Alessandro Armuzzi, Anneline Cremer

J Clin Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching biologics used in inflammatory bowel diseases: how to deal with in practice?
Claire Liefferinckx, Anneline Cremer, Denis Franchimont

Curr Opin Pharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy.
Uri Kopylov, Jurij Hanzel, Claire Liefferinckx, Davide De Marco, Nicola Imperatore, Anneline Cremer

Aliment Pharmacol Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Development of More-advanced Lesions in Patients With Inflammatory Bowel Diseases and Dysplasia.
Anneline Cremer, Pieter Demetter, Martine De Vos, Jean-François Rahier, Filip Baert

Clin Gastroenterol Hepatol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
Annick Moens, C Janneke van der Woude, Mette Julsgaard, Evelien Humblet, Juliette Sheridan, Anneline Cremer

Aliment Pharmacol Ther· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study.
Anneline Cremer, Jade Ku, Leila Amininejad, Marie-Rose Bouvry, Fabian Brohet

J Crohns Colitis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early vedolizumab trough levels at induction in inflammatory bowel disease patients with treatment failure during maintenance.
Claire Liefferinckx, Charlotte Minsart, Anneline Cremer, Leila Amininejad, Vjola Tafciu

Eur J Gastroenterol Hepatol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert opinion for use of faecal calprotectin in diagnosis and monitoring of inflammatory bowel disease in daily clinical practice.
Catherine Reenaers, Peter Bossuyt, Pieter Hindryckx, Hilde Vanpoucke, Anneline Cremer

United European Gastroenterol J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the 'United Registries for Clinical Assessment and Research' [UR-CARE], a European Online Registry for Clinical Care and Research in Inflammatory Bowel Disease.
Johan Burisch, Javier P Gisbert, Britta Siegmund, Dominik Bettenworth, Sandra Bohn Thomsen, Anneline Cremer

J Crohns Colitis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance.
Claire Liefferinckx, Charlotte Minsart, Jean-François Toubeau, Anneline Cremer, Leila Amininejad

Inflamm Bowel Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of bile stone disease and its complications.
Anneline Cremer, Marianna Arvanitakis

Minerva Gastroenterol Dietol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction of all-trans retinoic acid deficiency in alcoholic cirrhosis lessens the excessive inflammatory monocyte response: a translational study.
Romy Ouziel, Eric Trépo, Anneline Cremer, Christophe Moreno, Delphine Degré

Liver Int· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis